Journal list menu
IssueCancer Communications: Volume 43, Issue 5
i, 523-634May 2023
Export Citations
Download PDFs
FEATURED COVER
Cover Image, Volume 43, Issue 5
- Page: i
- First Published: 11 May 2023
The cover image is based on the Correspondence Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer by Stephen Keelan et al., https://doi.org/10.1002/cac2.12407.
ISSUE INFORMATION
REVIEW
Tumor microenvironment signaling and therapeutics in cancer progression
- Pages: 525-561
- First Published: 02 April 2023
ORIGINAL ARTICLES
High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway
- Pages: 562-581
- First Published: 08 April 2023
Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer
- Pages: 582-612
- First Published: 02 April 2023
RESEARCH HIGHLIGHT
Knowing nodal Rouviére: the power of human intelligence in toxicity reduction
- Pages: 613-614
- First Published: 17 April 2023
LETTERS TO THE EDITOR
Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer
- Pages: 615-619
- First Published: 20 January 2023
Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis
- Pages: 620-624
- First Published: 10 February 2023
Integrated circulating tumor DNA and T cell repertoire predict radiotherapeutic response and outcome in non-small cell lung cancer patients with brain metastasis
- Pages: 625-629
- First Published: 23 February 2023
Plasma small-extracellular vesicles enriched in miR-122-5p promote disease aggressiveness in pediatric anaplastic large-cell lymphoma
- Pages: 630-634
- First Published: 04 April 2023
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)